Compare ALCO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALCO | XBIT |
|---|---|---|
| Founded | 1960 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Pharmaceuticals and Biotechnology |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.7M | 73.2M |
| IPO Year | N/A | 2015 |
| Metric | ALCO | XBIT |
|---|---|---|
| Price | $37.54 | $2.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.5K | ★ 63.5K |
| Earning Date | 11-24-2025 | 11-12-2025 |
| Dividend Yield | ★ 0.53% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,066,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.76 | $2.09 |
| 52 Week High | $38.40 | $6.66 |
| Indicator | ALCO | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 61.84 | 52.78 |
| Support Level | $37.37 | $2.40 |
| Resistance Level | $38.40 | $2.55 |
| Average True Range (ATR) | 0.88 | 0.14 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 74.71 | 57.89 |
Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.